JP2012520665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520665A5 JP2012520665A5 JP2012500299A JP2012500299A JP2012520665A5 JP 2012520665 A5 JP2012520665 A5 JP 2012520665A5 JP 2012500299 A JP2012500299 A JP 2012500299A JP 2012500299 A JP2012500299 A JP 2012500299A JP 2012520665 A5 JP2012520665 A5 JP 2012520665A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- nucleic acid
- expression cassette
- peptide according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 244000045947 parasite Species 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000222722 Leishmania <genus> Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 239000002917 insecticide Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0951768 | 2009-03-19 | ||
| FR0951768A FR2943345B1 (fr) | 2009-03-19 | 2009-03-19 | Analogues de la temporine-sha et leurs utilisations |
| PCT/FR2010/050487 WO2010106293A1 (fr) | 2009-03-19 | 2010-03-18 | Analogues de la temporine-sha et leurs utilisations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012520665A JP2012520665A (ja) | 2012-09-10 |
| JP2012520665A5 true JP2012520665A5 (cg-RX-API-DMAC7.html) | 2013-04-25 |
| JP5713211B2 JP5713211B2 (ja) | 2015-05-07 |
Family
ID=41066385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012500299A Expired - Fee Related JP5713211B2 (ja) | 2009-03-19 | 2010-03-18 | テンポリン−ＳＨａ類縁体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9522942B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2408806A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5713211B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI1009585A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2755472C (cg-RX-API-DMAC7.html) |
| FR (1) | FR2943345B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010106293A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3385343B2 (ja) | 1996-12-26 | 2003-03-10 | Ｎｔｎ株式会社 | トリポード型等速自在継手 |
| EP2853538A1 (en) * | 2013-09-27 | 2015-04-01 | Université Pierre et Marie Curie (Paris 6) | Analogues of temporin-SHa and uses thereof |
| DK3087092T3 (en) * | 2013-12-12 | 2018-11-12 | Academisch Ziekenhuis Leiden | ANTIMICROBIAL PEPTID AND APPLICATIONS THEREOF |
| CN106117333A (zh) * | 2016-07-06 | 2016-11-16 | 贵州师范大学 | 合江棘蛙皮肤抗菌肽及其编码序列的基因及原核表达 |
| US10550155B2 (en) * | 2018-03-27 | 2020-02-04 | Farzana Shaheen | Anticancer peptides |
| CA3221235A1 (en) | 2021-06-11 | 2022-12-15 | Ali Ladram | Short antimicrobial peptides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992013958A1 (en) * | 1991-02-06 | 1992-08-20 | Georgetown University | Receptor blocking peptides of fibroblast growth factor receptor |
| US5916872A (en) * | 1996-07-24 | 1999-06-29 | Intrabiotics Pharmaceuticals, Inc. | Cyclic peptides having broad spectrum antimicrobial activity |
-
2009
- 2009-03-19 FR FR0951768A patent/FR2943345B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-18 BR BRPI1009585A patent/BRPI1009585A2/pt not_active IP Right Cessation
- 2010-03-18 US US13/257,018 patent/US9522942B2/en not_active Expired - Fee Related
- 2010-03-18 EP EP10716554A patent/EP2408806A1/fr not_active Withdrawn
- 2010-03-18 CA CA2755472A patent/CA2755472C/fr not_active Expired - Fee Related
- 2010-03-18 JP JP2012500299A patent/JP5713211B2/ja not_active Expired - Fee Related
- 2010-03-18 WO PCT/FR2010/050487 patent/WO2010106293A1/fr not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smith et al. | Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails | |
| CN114126629B (zh) | 用于生成一氧化氮的方法和组合物及其用于经由呼吸道输送一氧化氮的用途 | |
| JP2012520665A5 (cg-RX-API-DMAC7.html) | ||
| JP2012522037A5 (cg-RX-API-DMAC7.html) | ||
| JP2009526751A5 (cg-RX-API-DMAC7.html) | ||
| RS58980B1 (sr) | Peptidi i njihova upotreba | |
| CN114901291A (zh) | 抗菌有机硅烷 | |
| JP2009525284A (ja) | バイオフィルム関連感染を処置するためのガリウムの使用 | |
| EP3980373A1 (en) | Methods and compositions for generating nitric oxide and uses thereof | |
| JP2015512386A5 (cg-RX-API-DMAC7.html) | ||
| KR20150013280A (ko) | 박테리아 균막을 제거하기 위한 세아프로제의 용도 | |
| JP2023526584A (ja) | Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物 | |
| JP2023526583A (ja) | 結核を治療及び抑制するための方法及び組成物 | |
| Salmani-Zarchi et al. | Antimicrobial feature of nanoparticles in the antibiotic resistance era: from mechanism to application | |
| Ma et al. | Bioinspired nanomaterials for the treatment of bacterial infections | |
| WO2021019336A1 (en) | Antimicrobial compositions and articles comprising the same | |
| DK180380B1 (en) | Combination therapy compositions for use in treating a bacterial biofilm in a subject and methods for killing, inhibiting or preventing the growth of a bacterial biofilm in vitro | |
| EP1609473A8 (en) | Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria | |
| Singh | Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine | |
| JP6072047B2 (ja) | 感染症の治療のための抗菌ペプチド | |
| US20170107254A1 (en) | Modified Antimicrobial Peptides | |
| US11197824B2 (en) | Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus | |
| CN102940874A (zh) | 小分子多肽cw14在制备山羊抗菌药物中的应用 | |
| US20230172884A1 (en) | Use of bucillamine in the treatment of infectious diseases | |
| CN103285418A (zh) | 基于大面积烧伤创面用的新型生物抗菌敷料气雾剂 |